The landscape of dementia diagnosis has progressed considerably with the advent of innovative biomarkers, such as amyloid PET scans, tau imaging, and blood-dependent checks that may detect Alzheimer's pathology several years right before signs emerge. When these technological advances signify impressive development in understanding neurodegenerativ